Vaxcyte, Inc. Annual Operating Lease, Payments in USD from 2021 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Vaxcyte, Inc. quarterly/annual Operating Lease, Payments history and growth rate from 2021 to 2023.
  • Vaxcyte, Inc. Operating Lease, Payments for the quarter ending September 30, 2024 was $3.61M, a 116% increase year-over-year.
  • Vaxcyte, Inc. Operating Lease, Payments for the twelve months ending September 30, 2024 was $10.8M, a 64.5% increase year-over-year.
  • Vaxcyte, Inc. annual Operating Lease, Payments for 2023 was $7.39M, a 37.5% increase from 2022.
  • Vaxcyte, Inc. annual Operating Lease, Payments for 2022 was $5.37M, a 482% increase from 2021.
Operating Lease, Payments, Trailing 12 Months (USD)
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $7.39M +$2.02M +37.5% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-27
2022 $5.37M +$4.45M +482% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-27
2021 $924K Jan 1, 2021 Dec 31, 2021 10-K 2023-02-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.